Patent · US Active

Co-agonists at GLP-1 and GIP receptors suitable for oral delivery

US11779648B2 · kind B2 · utility

0Cited by

5References

1Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Patrick James Knerr · Plainfield, US
Brian Finan · Bloomington, US
Richard D. DiMarchi · Carmel, US

Key dates

Filing date	Jan 12, 2022
Grant date	Oct 10, 2023
Priority date	—
Expiry date	Jan 12, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptide co-agonists of the human GLP-1 and GIP receptors suitable for oral delivery, including long-acting derivatives, and their medical use in treatment and/or prevention of obesity, diabetes, and/or liver diseases are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.